4th Global Conference on Myositis, GCOM

ABSTRACT

The proceedings contain 255 papers. The topics discussed include molecular pathology of mitochondrial disorders;defining causal genes at MHC in SLE - implications for myositis and other diseases that share MHC risk;role of mitochondria in skeletal muscle dysfunction in myositis;selective T cell depletion for inclusion body myositis why and how;inclusion body myositis in 2022 from physiopathogenesis to clinical trials;autoantibodies and complement in experimental IMNM from pathogenesis to therapy?;reliability of immunoassays for myositis autoantibodies;when JM patients lose their 'J' transition challenges in myositis car;fatigue and well-being of children with chronic inflammatory disease;physical fitness in long-term JDM;Eular Covid and COVAX registries' update focus on myositis;and outcomes, biomarkers, and novel treatments for the skin in dermatomyositis.